Furthermore, recent lung autopsy findings have suggested that seriously ill patients with COVID-19 have considerably higher levels of a set of chemokines, including CCL2, CXCL5, and CXCL6, than moderately ill patients [53]. The gene discussed is CCL2; the disease is COVID-19.